HARBIN, China, July 6 /PRNewswire-Asia-FirstCall/ -- Weikang
Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) ("Weikang" or the
"Company"), a leading developer, manufacturer and marketer of Traditional
Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other
health and nutritional products in the People's Republic of China, today
announced that it will participate in the Global Hunter 2010 China Conference
on Tuesday, July 13, 2010.

Mr. Ren Hu, Vice President of Finance of Weikang, will present the
Company's operations, business strategy, financial results, and outlook as
well as answer investors' questions during the presentation and at one-on-one
meetings.

Weikang Bio-Technology Group Co., Inc. is principally engaged in
developing, manufacturing and distributing Traditional Chinese Medicine (TCM),
and health and nutritional supplements in China, in compliance with requisite
Chinese licenses and approvals. The Company is also expanding its business
scope to develop, manufacture and distribute Chinese herbal extract products
and GMP certified western prescription and OTC pharmaceuticals through its
acquisition of Tianfang. For more information, please visit
http://www.weikangbio.com .

Safe Harbor Statement

This press release contains certain statements that may include "forward
looking statements." All statements other than statements of historical fact
included herein are "forward-looking statements." These forward-looking
statements are often identified by the use of forward-looking terminology such
as "believes," "expects" or similar expressions, involve known and unknown
risks and uncertainties. Although the Company believes that the expectations
reflected in these forward-looking statements are reasonable, they do involve
assumptions, risks and uncertainties, and these expectations may prove to be
incorrect. You should not place undue reliance on these forward-looking
statements, which speak only as of the date of this press release. The
Company's actual results could differ materially from those anticipated in
these forward-looking statements as a result of a variety of factors,
including those discussed in the Company's periodic reports that are filed
with the Securities and Exchange Commission and available on its website
(http://www.sec.gov ). All forward-looking statements attributable to the
Company or persons acting on its behalf are expressly qualified in their
entirety by these factors. Other than as required under the securities laws,
the Company does not assume a duty to update these forward-looking statements.

(Date:12/8/2016)... , December 8, 2016 According ... Diabetes Injection Pens Market is expected to be worth ... US$4.9 bn in 2015. Between the forecast years of 2016 ... a CAGR of 7.9%. The leading players operating in the ... Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A. ...

(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged to ... mind, SIGVARIS has created a new line of anti-embolism stockings to help prevent ... the benefits of graduated compression when transitioning from recovery to early rehabilitation. , ...

(Date:12/8/2016)... , ... December 08, 2016 , ... The Compretta Insurance ... and residential clients in and around the Hancock County area, is announcing the launch ... County Food Pantry. , The Hancock County Food Pantry has worked for more than ...